Â鶹´«Ã½ earned an honorable mention in Mergers & Acquisitions’ 2025 for advising Ora, a leading global full-service ophthalmic drug and device development firm, in its 2024 recapitalization by The Vistria Group.
“Despite the continued slowdown of deals over the last year, the winning deals are notable for their innovation and obstacles they successfully navigated,” wrote Mergers & Acquisitions of the recognized transactions.
The Â鶹´«Ã½ team representing Ora was led by partner Susan Pravda and included partner Beth Felder, senior counsel Paige Moscow, and associate Grace Fucci, with assistance from partners Casey Knapp, Benjamin Dryden, John Palmer, Lynn Gandhi, of counsel Jeremy Abrams, senior counsel Kelsey O’Gorman, and additional support from partners Gabor Garai and Ethan Lenz.
To learn more about Â鶹´«Ã½’s representation of Ora in its recapitalization, click here.
